25 Years after HIV discovery: Prospects for cure and vaccine (Nobel Lecture)

Angewandte Chemie - International Edition

Volumn 48, Issue 32, 2009, Pages 5815-5826

  Montagnier, Luc ^a  

^a Prevention UNESCO   (France)

Author keywords

AIDS; HIV; Nobel Lecture; Virology

Indexed keywords

AIDS; CERVICAL CANCERS; HIV; HUMAN IMMUNODEFICIENCY VIRUS; NOBEL LECTURE; NOBEL PRIZES; VIROLOGY;

MICROBIOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ART; AWARDS AND PRIZES; FRANCE; HISTORY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; ISOLATION AND PURIFICATION; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS VACCINES; FRANCE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HIV; HIV INFECTIONS; NOBEL PRIZE; VIROLOGY;

EID: 70349898696     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200902130     Document Type: Article

References (25)

1. "Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)": F. Barré-Sinoussi, J. C. Chermann, F. Rey, M. T. Nugeyre, S. Chamaret, J. Gruest, C. Dauguet, C. Axler-Blin, F. Vézinet-Brun, C. Rou-zioux, W. Rozenbaum, L. Montagnier, Science 1983, 220, 868-871.
2. "Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome": F. Brun-Vezinet, F. Barre-Sinoussi, A. G. Saimot, D. Christol, L. Montagnier, C. Rouzioux, D. Klatzmann, W. Rozenbaum, J. C. Gluckman, J. C Chermann, Lancet 1984, 1253-1256.
3. "Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes": D. Klatzmann, F. Barré-Sinoussi, M. T. Nugeyre, C. Dauguet, E. Vilmer, C. Griscelli, F. Brun-Vézinet, C. Rouzioux, J. C. Gluckman, J. C. Chermann, L. Montagnier, Science 1984, 225, 59-63.
4. "Adaptation of Lymphadenopathy Associated Virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines": L. Montagnier, J. Gruest, S. Chamaret, C. Dauguet, C. Axler, D. Guetard, M. T. Nugeyre, F. Barré-Sinoussi, J. C. Chermann, J. B. Brunet, D. Klatzmann, J. C. Gluckman, Science 1984, 225, 63-66.
5. "LAV revisited: origins of the early HIV-1 isolates from Institut Pasteur": S. Wain-Hobson, J. P. Vartanian, M. Henry, N. Chenciner, R. Cheynier, S. Delassus, L. Pedroza Martins, M. Sala, M. T. Nugeyre, D. Guetard, D. Klatzmann, J. C. Gluckman, W. Rozenbaum, F. Barré-Sinoussi, L. Montagnier, Science 1991, 252, 961-965.
6. "A new human T-lymphotropic retrovirus: characterization and possible role in lymphadenopathy and acquired immune deficiency syndromes": L. Montagnier, J. C. Chermann, F. Barré-Sinoussi, S. Chamaret, J. Gruest, M. T. Nugeyre, F. Rey, C. Dauguet, C. Axler-Blm, F. Vézinet-Brun, C. Rouzioux, G. A. Saimot, W. Rozenbaum, J. C. Gluckman, D. Klatzmann, E. Vilmer, C. Griscelli, C. Foyer-Gazengel, J. B. Brunet in Human T cell leukemia/lymphoma viruses (Eds.: R. C. Gallo, M. E. Essex, L. Gross), Cold Spring Harbor Laboratory, New York, 1984, pp. 363-379.
7. "Detection, isolation and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS": M. Popovic, M. G. Sarngadharan, E. Read, R. C. Gallo, Science 1984, 224, 497-500.
8. "Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS": J. A. Levy, A. D. Hoffman, S. M. Kramer, J. A. Lanois, J. M. Shimabukuro, L. S. Oskiro, Science 1984, 225, 840-842.
9. "Molecular cloning of lymphadenopathy-associated virus": M. Alizon, P. Sonigo, F. Barre-Sinoussi, J. C. Chermann, P. Tiollais, L. Montagnier, S. Wain-Hobson, Nature 1984, 312, 757-760.
10. "Nucleotide sequence of AIDS virus, LAV": S. Wain-Hobson, P. Sonigo, O. Danos, S. Cole, M. Alizon, Cell 1985, 40, 9-17.
11. "Complete nucleotide sequence of the AIDS virus, HTLV-III": L. Ratner, W. Haseltine, R. Patarca, K. J. Livak, B. Starcich, S. F. Josephs, E. R. Doran, A. Rafalski, E. A. Whitchorn, K. Bau-meister, L. Ivanoff, S. R. Petteway, M. L. Pearson, J. A. Lauten-bergen, T. S. Papas, J. Ghrayeb, N. T. Chang, R. C. Gallo, F. Wong-Staal, Nature 1985, 313, 277-284.
12. "Isolation of a new human retrovirus from West African patients with AIDS": F. Clavel, D. Guetard, F. Brun-Vezinet, S. Chamaret, M. A. Rey, M. O. Santos-Ferreira, A. G. Laurent, C. Daughet, C. Katlama, C. Rouzioux, D. Klatzmann, J. L. Cham-palimaud, L. Montagnier, Science 1986, 233, 343-346.
13. "Transmissibility of human immunodeficiency virus in haemo-philic and non-haemophilic children living in a private school in France": A. Berthier, S. Chamaret, R. Fauchet, J. Fonlupt, N. Genetet, M. Gueguen, M. Pommereuil, A. Ruffault, L. Montagnier, Lancet 1986, 598-601.
14. "Concorde: MCR/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection": M. Seligmann, D. A. Warrel, J.-P. Aboulker, C. Carbon, J. H. Darbyshire, J. Dormont, E. Eschwege, D. J. Girling, D. R. James, J.-P. Levy, P. T. A. Peto, D. Schwarz, A. B. Stone, I. V. D. Weller, R. Withnall, K. Gehnon, E. Lafon, A. M. Swart, V. R. Aber, A. G. Babiker, S. Lhoro, A. J. Nunn, M. Vray, Lancet 1994, 343, 871-881.
15. M. Zuniga, A. Whiteside, A. Ghaziani, J. G. Bartlett (Preface by L. Montagnier/R. Gallo R), A Decade of HAART. The Development and Global Impact of Highly A ctive A ntiretroviral Therapy, Oxford University Press, Oxford, 2008.
16. "Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein": A.M. Sheehy, N. C. Gaddis, J. D. Choi, M. H. Malim, Nature 2002, 418, 646-650.
17. "Mise en évidence d'un processus d'engagement vers la mort cellulaire par apoptose dans les lymphocytes de patients infectés parle VIH": M. L. Gougeon, R. Olivier, S. Garcia, D. Guetard, T. Dragic, C. Dauguet, L. Montagnier, C. R. Acad. Sci. Sen III 1991, 312, 529-537.
18. "Programmed cell-death in AIDS-related HIV and SIV infections": M. L. Gougeon, S. Garcia, J. Heeney, R. Tschopp, H. Lecoeur, D. Guetard, V. Rame, C. Dauguet, L. Montagnier, AIDS Res. Hum. Retroviruses 1993, 9, 553-563.
19. "Programmed cell death in peripheral lymphocytes from HIV-infected persons: Increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression": M. L. Gougeon, H. Lecoeur, A. Dulioust, M. G. Enouf, M. Crouvoisier, C. Goujard, T. Debord, L. Montagnier, J. Immunol. 1996, 156, 3509-3520.
20. "Oxidative protein damage and degradation in lymphocytes from patients infected with human immunodeficiency virus": G. Piedimonte, D. Guetard, M. Magnani, D. Corsi, I. Picemo, P. Spataro, L. Kramer, M. Montroni, G. Silvestri, J. F. Torres-Roca, L. Montagnier, J. Infect. Dis. 1997, 176, 655-664.
21. "Increased plasma thiobarbituric acid-reactive substances (TEARS) before opportunistic infection symptoms in HIV-infected individuals": O. Lopez, D. Bonnefont-Rousselot, M. Mollereau, R. Olivier, L. Montagnier, J. Emerit, M. Gentilini, J. Delattre, Clin. Chim. Acta 1996, 247, 181-187.
22. "The human immunodeficiency virus-1 Tat protein increases cell proliferation, alters sensitivity to zinc chelator-induced apoptisis, and changes Spl DNA binding in HeLa cells": M. Sevea, A. Faviera, M. Osmana, D. Hernandez, G. Vaitaitis, N. C. Flores, J. M. McCord, S. C. Flores, Arch. Biochem. Biophys. 1999, 361, 165-172.
23. "In vitro influence of Mycoplasma penetrans on activation of peripheral T lymphocytes from healthy donors or human immunodeficiency virus-infected individuals": Y. Sasaki, A. Blanchard, H. L. Watson, S. Garcia, A. Dulioust, L. Montagnier, M. L. Gougeon, Infect. Immun. 1995, 63, 4277-4283.
24. "The challenge of finding a cure for HIV infection": D. D. Richman, D. M. Margolis, M. Delaney, C. Warner Grenne, D. Hazuda, R. J. Pomerantz, Science 2009, 323, 1304-1307.
25. "Toward functional eradication of HIV infection": L. Montagnier, Future HIV Ther. 2007, 1, 3-4.